Contribution of the BRAF oncogene in the pre‑operative phase of thyroid carcinoma
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFBA |
Texto Completo: | http://repositorio.ufba.br/ri/handle/ri/15045 |
Resumo: | Texto completo: acesso restrito. p. 191-196 |
id |
UFBA-2_e1d2e7fd965bd6694da03e17e1266824 |
---|---|
oai_identifier_str |
oai:repositorio.ufba.br:ri/15045 |
network_acronym_str |
UFBA-2 |
network_name_str |
Repositório Institucional da UFBA |
repository_id_str |
1932 |
spelling |
Rodrigues, Homero Gustavo CorreiaPontes, Alana Abrantes Nogueira DeAdan, Luís Fernando FernandesRodrigues, Homero Gustavo CorreiaPontes, Alana Abrantes Nogueira DeAdan, Luís Fernando Fernandes2014-06-04T16:18:52Z20131792-1074http://repositorio.ufba.br/ri/handle/ri/15045v. 6, n. 1Texto completo: acesso restrito. p. 191-196Numerous experiments have been conducted over the last few years aiming to identify molecular markers that show the diagnostic accuracy of fine‑needle aspiration (FNA), particularly in thyroid lesions that are considered indeterminate. Using certain search arguments and previously defined criteria, 37 studies reporting experiments with the BRAF mutation in pre‑operative FNA of the thyroid were selected from the electronic databases PUBMED, MEDLINE, SCOPUS and LILACS, in order to gather evidence with regard to the possible contribution of BRAF in the management of thyroid carcinoma. There were no cases positive for BRAF in follicular carcinomas (FTCs), Hürthle cell carcinomas (HCCs) or medullary thyroid carcinomas (MTCs). Among the 11 cases of anaplastic thyroid carcinomas (ATC), three showed positive results for the BRAF mutation. The number of cases positive for BRAF among the benign lesions was not significant. The average prevalence of BRAF‑positive cases in papillary carcinomas (PTC) was 58.6%, while in follicular variants of papillary carcinoma (FVPTC), the average prevalence was 29.6%. For lesions diagnosed as indeterminate or suspicious, the average prevalence of BRAF positivity in PTC was 48.5%. The experiments included in the present study indicated a specificity of almost 100% and a high predominance of the BRAF mutation in PTC, distinguishing the marker in the planning and medical management of papillary carcinoma of the thyroid.Submitted by Suelen Reis (suziy.ellen@gmail.com) on 2014-05-20T14:19:08Z No. of bitstreams: 1 10.3892-ol.2013.1359.pdf: 318221 bytes, checksum: 7593a43009f189b1958d769f3a374ff3 (MD5)Approved for entry into archive by Flávia Ferreira (flaviaccf@yahoo.com.br) on 2014-06-04T16:18:52Z (GMT) No. of bitstreams: 1 10.3892-ol.2013.1359.pdf: 318221 bytes, checksum: 7593a43009f189b1958d769f3a374ff3 (MD5)Made available in DSpace on 2014-06-04T16:18:52Z (GMT). No. of bitstreams: 1 10.3892-ol.2013.1359.pdf: 318221 bytes, checksum: 7593a43009f189b1958d769f3a374ff3 (MD5) Previous issue date: 2013http://dx.doi.org/10.3892/ol.2013.1359reponame:Repositório Institucional da UFBAinstname:Universidade Federal da Bahia (UFBA)instacron:UFBAFine‑needle aspirationBRAF mutationPapillary thyroid carcinomaOncogenesCarcinomaThyroid GlandContribution of the BRAF oncogene in the pre‑operative phase of thyroid carcinomaOncology Lettersinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article10000-01-01info:eu-repo/semantics/openAccessengORIGINAL10.3892-ol.2013.1359.pdf10.3892-ol.2013.1359.pdfapplication/pdf318221https://repositorio.ufba.br/bitstream/ri/15045/1/10.3892-ol.2013.1359.pdf7593a43009f189b1958d769f3a374ff3MD51LICENSElicense.txtlicense.txttext/plain1345https://repositorio.ufba.br/bitstream/ri/15045/2/license.txt0d4b811ef71182510d2015daa7c8a900MD52TEXT10.3892-ol.2013.1359.pdf.txt10.3892-ol.2013.1359.pdf.txtExtracted texttext/plain32721https://repositorio.ufba.br/bitstream/ri/15045/3/10.3892-ol.2013.1359.pdf.txt9d4dea8978da3965052d40d62fadf6f6MD53ri/150452022-07-05 14:03:30.997oai:repositorio.ufba.br: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Repositório InstitucionalPUBhttp://192.188.11.11:8080/oai/requestopendoar:19322022-07-05T17:03:30Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA)false |
dc.title.pt_BR.fl_str_mv |
Contribution of the BRAF oncogene in the pre‑operative phase of thyroid carcinoma |
dc.title.alternative.pt_BR.fl_str_mv |
Oncology Letters |
title |
Contribution of the BRAF oncogene in the pre‑operative phase of thyroid carcinoma |
spellingShingle |
Contribution of the BRAF oncogene in the pre‑operative phase of thyroid carcinoma Rodrigues, Homero Gustavo Correia Fine‑needle aspiration BRAF mutation Papillary thyroid carcinoma Oncogenes Carcinoma Thyroid Gland |
title_short |
Contribution of the BRAF oncogene in the pre‑operative phase of thyroid carcinoma |
title_full |
Contribution of the BRAF oncogene in the pre‑operative phase of thyroid carcinoma |
title_fullStr |
Contribution of the BRAF oncogene in the pre‑operative phase of thyroid carcinoma |
title_full_unstemmed |
Contribution of the BRAF oncogene in the pre‑operative phase of thyroid carcinoma |
title_sort |
Contribution of the BRAF oncogene in the pre‑operative phase of thyroid carcinoma |
author |
Rodrigues, Homero Gustavo Correia |
author_facet |
Rodrigues, Homero Gustavo Correia Pontes, Alana Abrantes Nogueira De Adan, Luís Fernando Fernandes |
author_role |
author |
author2 |
Pontes, Alana Abrantes Nogueira De Adan, Luís Fernando Fernandes |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Rodrigues, Homero Gustavo Correia Pontes, Alana Abrantes Nogueira De Adan, Luís Fernando Fernandes Rodrigues, Homero Gustavo Correia Pontes, Alana Abrantes Nogueira De Adan, Luís Fernando Fernandes |
dc.subject.por.fl_str_mv |
Fine‑needle aspiration BRAF mutation Papillary thyroid carcinoma Oncogenes Carcinoma Thyroid Gland |
topic |
Fine‑needle aspiration BRAF mutation Papillary thyroid carcinoma Oncogenes Carcinoma Thyroid Gland |
description |
Texto completo: acesso restrito. p. 191-196 |
publishDate |
2013 |
dc.date.issued.fl_str_mv |
2013 |
dc.date.accessioned.fl_str_mv |
2014-06-04T16:18:52Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://repositorio.ufba.br/ri/handle/ri/15045 |
dc.identifier.issn.none.fl_str_mv |
1792-1074 |
dc.identifier.number.pt_BR.fl_str_mv |
v. 6, n. 1 |
identifier_str_mv |
1792-1074 v. 6, n. 1 |
url |
http://repositorio.ufba.br/ri/handle/ri/15045 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.pt_BR.fl_str_mv |
http://dx.doi.org/10.3892/ol.2013.1359 |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFBA instname:Universidade Federal da Bahia (UFBA) instacron:UFBA |
instname_str |
Universidade Federal da Bahia (UFBA) |
instacron_str |
UFBA |
institution |
UFBA |
reponame_str |
Repositório Institucional da UFBA |
collection |
Repositório Institucional da UFBA |
bitstream.url.fl_str_mv |
https://repositorio.ufba.br/bitstream/ri/15045/1/10.3892-ol.2013.1359.pdf https://repositorio.ufba.br/bitstream/ri/15045/2/license.txt https://repositorio.ufba.br/bitstream/ri/15045/3/10.3892-ol.2013.1359.pdf.txt |
bitstream.checksum.fl_str_mv |
7593a43009f189b1958d769f3a374ff3 0d4b811ef71182510d2015daa7c8a900 9d4dea8978da3965052d40d62fadf6f6 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA) |
repository.mail.fl_str_mv |
|
_version_ |
1808459478709829632 |